Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/47633
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_In-situFormationNanoparticles.pdf4,67 MBAdobe PDFVisualizar/Abrir
Título: In-situ formation of nanoparticles from drug-loaded 3D polymeric matrices
Autor(es): Pires, Felipe Queiroz
Gross, Idejan Padilha
Barreto, Livia Cristina Lira de Sá
Gratieri, Taís
Gelfuso, Guilherme Martins
Báo, Sônia Nair
Cunha Filho, Marcílio Sérgio Soares da
Afiliação do autor: University of Brasilia, School of Health Sciences, Laboratory of Food, Drugs and Cosmetics
University of Brasilia, School of Health Sciences, Laboratory of Food, Drugs and Cosmetics
University of Brasilia, Faculty of Ceilandia
University of Brasilia, School of Health Sciences, Laboratory of Food, Drugs and Cosmetics
University of Brasilia, School of Health Sciences, Laboratory of Food, Drugs and Cosmetics
University of Brasilia, Institute of Biological Sciences, Laboratório de Microscopia e Microanálise
University of Brasilia, School of Health Sciences, Laboratory of Food, Drugs and Cosmetics
Assunto: Naringenina
Nanopartículas
Medicamentos
Data de publicação: 3-Jul-2023
Editora: Elsevier B.V.
Referência: PIRES, Felipe Q. et al. In-situ formation of nanoparticles from drug-loaded 3D polymeric matrices. European Journal of Pharmaceutical Sciences, v. 188,106517, 1 set. 2023. DOI: https://doi.org/10.1016/j.ejps.2023.106517. Disponível em: https://www.sciencedirect.com/science/article/pii/S0928098723001471?via%3Dihub. Acesso em: 02 fev. 2024.
Abstract: The in-situ formation of nanoparticles from polymer-based solid medicines, although previously described, has been overlooked despite its potential to interfere with oral drug bioavailability. Such polymeric pharmaceuticals are becoming increasingly common on the market and can become even more popular due to the dizzying advance of 3D printing medicines. Hence, this work aimed to study this phenomenon during the dissolution of 3D printed tablets produced with three different polymers, hydroxypropylmethylcellulose acetate succinate (HPMCAS), polyvinyl alcohol (PVA), and Eudragit RL PO® (EUD RL) combined with plasticizers and the model drug naringenin (NAR). The components’ interaction, dissolution behavior, and characteristics of the formed particles were investigated employing thermal, spectroscopic, mechanical, and chromatographic assays. All the systems generated stable spherical-shaped particles throughout 24 h, encapsulating over 25% of NAR. Results suggest encapsulation efficiencies variations may depend on interactions between polymer-drug, drug-plasti cizer, and polymer-plasticizer, which formed stable nanoparticles even in the drug absence, as observed with the HPMCAS and EUD RL formulations. Additionally, components solubility in the medium and previous formulation treatments are also a decisive factor for nanoparticle formation. In particular, the treatment provided by hot-melt extrusion and FDM 3D printing affected the dissolution efficiency enhancing the interaction between the com ponents, reverberating on particle size and particle formation kinetics mainly for HPMCAS and EUD RL. In conclusion, the 3D printing process influences the in-situ formation of nanoparticles, which can directly affect oral drug bioavailability and needs to be monitored.
Unidade Acadêmica: Faculdade UnB Ceilândia (FCE)
Curso de Farmácia (FCE-FAR)
Faculdade de Ciências da Saúde (FS)
Departamento de Farmácia (FS FAR)
Instituto de Ciências Biológicas (IB)
Departamento de Biologia Celular (IB CEL)
Licença: This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
DOI: https://doi.org/10.1016/j.ejps.2023.106517
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro completo do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.